普罗吉尼生育健康

最新新闻

• Citizens JMP Maintains Progyny(PGNY.US) With Buy Rating, Raises Target Price to $33
  \u5e02\u573a\u8d44\u8baf · 2026/9/8
• 评级变动
  CCORF Maintains Progyny(PGNY.US) With Buy Rating, Raises Target Price to $36
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• 评级变动
  Leerink Partners Maintains Progyny(PGNY.US) With Buy Rating, Announces Target Price $38
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• Barclays Maintains Progyny(PGNY.US) With Hold Rating, Cuts Target Price to $30
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• 评级变动
  BTIG Maintains Progyny(PGNY.US) With Buy Rating, Raises Target Price to $40
  \u5e02\u573a\u8d44\u8baf · 2026/7/24
• 评级变动
  CCORF Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $35
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• Wells Fargo Initiates Progyny(PGNY.US) With Buy Rating, Announces Target Price $37
  \u5e02\u573a\u8d44\u8baf · 2026/8/20
• J.P. Morgan Maintains Progyny(PGNY.US) With Hold Rating, Raises Target Price to $30
  \u5e02\u573a\u8d44\u8baf · 2026/8/21
• 评级变动
  Barclays Downgrades Progyny(PGNY.US) to Hold Rating, Raises Target Price to $34
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• 评级变动
  Barclays Maintains Progyny(PGNY.US) With Hold Rating, Maintains Target Price $34
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  BofA Securities Maintains Progyny(PGNY.US) With Buy Rating, Announces Target Price $31
  \u5e02\u573a\u8d44\u8baf · 2026/6/2
• 评级变动
  CCORF Maintains Progyny(PGNY.US) With Buy Rating, Cuts Target Price to $35
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  CCORF Upgrades Progyny(PGNY.US) to Buy Rating, Raises Target Price to $30
  \u5e02\u573a\u8d44\u8baf · 2026/5/19
• 评级变动
  CCORF Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $30
  \u5e02\u573a\u8d44\u8baf · 2026/5/19
• 评级变动
  BofA Securities Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $31
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $31 to $35
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• 评级变动
  KeyBanc Maintains Progyny(PGNY.US) With Buy Rating, Raises Target Price to $35
  \u5e02\u573a\u8d44\u8baf · 2026/7/13
• Truist Financial Maintains Progyny(PGNY.US) With Buy Rating, Announces Target Price $36
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  Truist Financial Maintains Progyny(PGNY.US) With Buy Rating, Raises Target Price to $33
  \u5e02\u573a\u8d44\u8baf · 2026/6/22
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), Progyny (PGNY) and Adicet Bio (ACET)
  TipRanks · 2026/8/12

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。